Embolism and Thrombosis clinical trials

The registry lists 53 studies for Embolism and Thrombosis across more than 10 countries. 11 are recruiting or about to start. 12 of them are mainly about Embolism and Thrombosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23. Counting its 14 narrower conditions too, such as Thrombosis: 3,348 studies, 580 open.

Get an email when these change. Save the Embolism and Thrombosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 31
Recruiting: 9
Status unknown: 5
Active, not recruiting: 3
Not yet recruiting: 2
Terminated: 2

Phase

Phase 4: 8
Phase 2: 6
Phase 3: 4
Phase 1: 3

Where

Netherlands: 11
Belgium: 10
France: 9
United States: 9
Canada: 8
Italy: 8

Who runs them

Bayer (4) · University Hospital, Brest (3) · Chinese Academy of Medical Sciences, Fuwai Hospital (3) · LumiraDx UK Limited (2) · Insel Gruppe AG, University Hospital Bern (2) · Daiichi Sankyo Co., Ltd. (2) · St. Antonius Hospital (2) · Intervene, Inc. (1)

What is being tested here

Drugs under test in Embolism and Thrombosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Rivaroxaban	3	0	6
Aspirin	1	0	3
Apixaban	1	0	1
Edoxaban	0	2	3
Clopidogrel	0	0	2
Dexamethasone	0	1	1
Tirofiban	0	0	1
Fondaparinux	0	0	1
Dalteparin	0	0	1
Certoparin	0	1	1

Drug classes tested here Factor Xa inhibitors 3 open

Coming up

0phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Dec 2026Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis · Chinese Academy of Medical Sciences, Fuwai Hospital
Dec 2026Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis · Insel Gruppe AG, University Hospital Bern
Jan 2027Observational Dutch Young Symptomatic StrokE studY - nEXT · Radboud University Medical Center
Oct 2027STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant · Chinese Academy of Medical Sciences, Fuwai Hospital

Who these studies take

Of the 9 Embolism and Thrombosis studies recruiting now, 7 (78%) set no upper age limit and 1 (11%) stop at 75 or younger. 2 (22%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 9
Age	Women	Men
10	2 (22%)	2 (22%)
18	9 (100%)	9 (100%)
30	9 (100%)	9 (100%)
40	9 (100%)	9 (100%)
50	9 (100%)	9 (100%)
65	8 (89%)	8 (89%)
75	8 (89%)	8 (89%)
85	7 (78%)	7 (78%)

Across all 53 studies, recruiting or not: 6% stop at 75 or younger and 4% at 65; 6% take children; 4% are for women only and 2% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.